Plasma-Activated Water (PAW) for Fertilization Market Size & Share 2026-2035

Plasma-Activated Water (PAW) for Fertilization Market Size

The plasma-activated water for fertilization market was valued at USD 24.5 million in 2025 and will reach USD 559.3 million by 2035, expanding at a 36.2% CAGR from 2026 to 2035. According to the latest report published by Global Market Insights Inc., the market reaches USD 34.6 million in 2026.

PAW uses non-thermal plasma to convert air and water into nitrate, nitrite, and reactive oxygen species, creating an on-site input for fertigation, seed treatment, and plant-health applications. Its commercial relevance rests on replacing part of a centralized, fossil-fuel-intensive nitrogen supply chain with distributed production at the point of use. ^{[1]Intergovernmental Panel on Climate Change, Climate mitigation and agricultural nitrogen efficiency. ipcc.ch}

Market estimates cover PAW systems and associated services used to generate nitrogen-enriched water for crop nutrition, seed priming, foliar treatment, and related agricultural uses. They exclude PAW equipment used solely for sanitation, swimming pools, livestock drinking water, or industrial water treatment. The base year is 2025; historic analysis spans 2022-2025, and forecasts cover 2026-2035. The sizing approach triangulates demand across controlled environment agriculture (CEA), open-field farms, organic growers, nurseries, and research institutions with parent-market filtering and revenue aggregation across active suppliers.

The market expanded at a 36.1% historic CAGR between 2022 and 2025. Forecast expansion depends less on a single technical breakthrough than on three linked changes: lower reactor manufacturing cost, credible crop-specific dosing evidence, and distribution channels that lower the first-deployment burden for growers. Europe remains the commercial anchor, while Asia Pacific supplies the fastest regional growth profile as decentralized nitrogen production aligns with solar-powered agricultural infrastructure.

The market is moving from trial-led adoption toward commercial integration in greenhouse, specialty-crop, and decentralized nutrient systems. Continuous-flow and microbubble configurations address throughput and energy-use constraints, while peer-reviewed work on DBD and distributed electric-field plasma improves the agronomic and engineering evidence base. ^{[2]Nature Communications, Plasma nitrogen fixation via spatially distributed electric field strategy. nature.com} The technology's most immediate commercial advantage is not nitrogen output alone. It is the ability to combine localized production, nutrient delivery, and, in selected applications, plant-health value within existing water-management workflows.

Key Drivers

Demand for lower-carbon nitrogen is the largest demand-side driver because PAW creates a route to produce nitrogen compounds using air, water, and electricity rather than relying exclusively on centralized Haber-Bosch supply. That value increases where growers face fertilizer-price volatility, transport exposure, or sustainability reporting requirements. Climate mitigation frameworks place agricultural nitrogen efficiency within broader emissions-reduction efforts. The commercial benefit is strongest when renewable electricity is available and PAW displaces a meaningful share of purchased nitrogen rather than operating as an isolated demonstration system.

CEA creates the most compatible operating environment. Recirculating hydroponic and aeroponic systems require traceable, precisely dosed inputs and can integrate PAW upstream of fertigation injection points. The CEA Alliance identifies controlled production systems as a growing component of modern food supply, particularly where water management and crop consistency matter. ^{[3]CEA Alliance, Controlled environment agriculture industry data. ceaindustry.org} This operational fit explains why greenhouse deployments have become the early reference base for suppliers such as VitalFluid and Aqtiva Inc.

On-site production adds a supply-resilience rationale. Farm or greenhouse operators can reduce exposure to transport, storage, and procurement cycles when the system converts local water and air into a usable nutrient stream. The result is most relevant in the Nordics, the Netherlands, and North American production clusters, where early projects have tested decentralized plasma-nitrogen models. Government programs that support nutrient efficiency and solar-powered agricultural infrastructure can improve the financing case, but formal PAW-specific eligibility remains uneven.

Key Restraints

Capital cost remains the first barrier for farms whose crop margins do not justify a dedicated reactor. Payback depends on electricity prices, water throughput, nitrogen-intensity requirements, crop value, and the ability to use the system across several functions. Modular equipment, manufacturing scale, and equipment-as-a-service models can reduce that barrier, but they have not yet normalized across the market. The constraint is particularly acute in open-field commodity crops, where conventional fertilizer remains comparatively inexpensive at the farm gate.

PAW composition can vary by plasma source, exposure time, water chemistry, and operating conditions. The absence of widely adopted application protocols leaves growers and agronomists with uncertainty around concentration, dose, crop tolerance, and interactions with other nutrient inputs. Research on DBD process optimization and commercial field trials advances the evidence base, but standardization still determines whether solutions can move from bespoke advisory engagements to repeatable deployments. ^{[4]MDPI Applied Sciences, Optimization framework for PAW-based nitrate fertilizer production. mdpi.com}

Plasma-Activated Water (PAW) for Fertilization Market Segment Analysis

By Plasma Generation Technology

DBD held the largest technology share at 42.5% in 2025 because it combines established non-thermal plasma operation with the widest commercial and agronomic validation base. DBD activates ambient nitrogen and oxygen into species that dissolve into water as nitrate, nitrite, and reactive oxygen compounds. VitalFluid's continuous greenhouse systems and surface-DBD tomato trials provide commercial and research references for this route. ^{[5]BMC Plant Biology, Surface DBD-derived PAW research. bmcplantbiol.biomedcentral.com} DBD will remain the revenue leader through 2035, although corona discharge will outpace it slightly as lower-cost configurations find use in smaller farms and seed-treatment facilities.

Atmospheric pressure plasma jets (APPJ) accounted for 15.1% in 2025 and are relevant where direct foliar treatment complements waterborne delivery. Aqtiva Inc. combines APPJ with microbubble transfer for North American CEA and specialty-crop applications. Microwave discharge serves high-value production settings that require concentrated reactive nitrogen delivery, while gliding arc designs provide a route toward ruggedized field systems. AJ Plasmatech and Green Lightning illustrate the commercial interest in arc-based equipment. The technology mix will remain plural because water volume, crop value, application mode, and capital tolerance differ materially across buyers.

By Application

Irrigation and fertilization generated 49.5% of 2025 application revenue. Its leadership reflects direct compatibility with drip, sprinkler, and recirculating fertigation infrastructure. Nordic and UK work on plasma-treated organic fertilizer reported mineral fertilizer equivalent values of up to 96 and ammonia-emission reductions of 70-89% in field application. ^{[6]Aarhus University, Nitrogen-enriched fertilizer field trial results. aarhus.dk} These results give the segment a practical performance reference, although crop-specific protocols remain essential before large-scale substitution claims can be generalized.

Seed treatment and priming held 30.3% share and provides the lowest-infrastructure commercialization route. Centralized treatment at seed companies or cooperatives removes the need for every grower to acquire a plasma system. Studies across wheat, barley, tomato, bell pepper, and maize reported germination improvements of 15-25% versus untreated controls; maize results rose from 65% to above 90% with a 37.5% reduction in median germination time. Foliar application and plant protection will post the fastest application CAGR at 37.1%, supported by VitalFluid greenhouse trials. Post-harvest treatment remains a smaller research-led use case, and Eddaion's equipment is principally relevant to sterilization rather than fertilization-grade nitrogen delivery.

By End-User

CEA led end-user demand with 37.4% share in 2025. Greenhouses, vertical farms, and hydroponic operations value precision delivery, low residue exposure, and continuous availability. VitalFluid's 24/7 greenhouse systems and HydroPlasma.Tech's hydroponic and aquaponic positioning show how suppliers target closed-loop production settings. Primary research conducted among 68 CEA operators and commercial greenhouse growers in 12 countries during Q3 2025 found that 41% were actively evaluating on-site plasma nitrogen generation, with supply resilience ranking ahead of cost savings and yield improvement as an adoption rationale.

Open-field agriculture held 27.3% share but represents the broader volume opportunity once equipment costs align with commodity crop economics. Corona and gliding arc designs can improve affordability for this group. Nurseries and horticulture will record the fastest end-user CAGR at 37.2%, benefiting from frequent-use cycles and the value of combined nutrition and pathogen-control applications. Organic farms, which accounted for 12.1%, could accelerate if certification bodies provide clearer treatment of PAW under EU Regulation 2018/848 and the U.S. National Organic Program. Research institutions remain important as the trial and standardization channel rather than as the principal volume driver.

By Crop Type

Vegetables accounted for 49.3% of 2025 revenue because CEA is concentrated in leafy greens, tomatoes, bell peppers, and herbs. Tomato results from surface-DBD PAW demonstrate the strongest full-cycle crop evidence in the current data set. Vegetables will remain the commercial anchor through 2030, when high crop value can absorb a premium for precise, traceable nutrient inputs.

Cereals and grains accounted for 22.3% and offer the largest long-run acreage opportunity, although capital cost limits immediate penetration. Plasma Waters' India activity through the Samunnati farmer producer organization channel is a relevant test of smallholder distribution. Fruits held 18.1%, where residue-free nutrient delivery and plant-health considerations support premium economics. Other crops, including ornamental floriculture and specialty non-food crops, will be the fastest-growing category at 37.5% CAGR because growers can place higher value on nutrient control and disease-risk management.

Plasma-Activated Water (PAW) for Fertilization Market Regional Analysis

Europe

Europe led the market with 41.8% share in 2025 and will reach USD 231.27 million by 2035. The Netherlands-based innovation cluster, greenhouse density, and EU focus on nutrient efficiency have created the market's most mature commercial setting. EU Regulation 2018/848 has increased attention on permissible nitrogen inputs for organic production. ^{[7]EUR-Lex, Regulation (EU) 2018/848 on organic production. eur-lex.europa.eu} Aarhus University and SEGES Innovation reported January 2025 results for plasma-treated nitrogen-enriched fertilizer that combined mineral fertilizer equivalent values of up to 96 with lower ammonia emissions. Germany, the Netherlands, the UK, France, Spain, and Italy supply the primary European demand base. VitalFluid's regional greenhouse footprint and PAWER Solutions' Spain-based corona-discharge activity support different entry routes.

North America

North America held 35.1% share in 2025 and will reach USD 197.21 million by 2035. The U.S. generated USD 7.20 million in 2025, supported by high-value greenhouse crops, land-grant research, and a growing domestic supplier base. Canada contributes through greenhouse horticulture in Ontario and British Columbia. The USDA EQIP and CSP may provide co-financing pathways, but PAW-specific eligibility has not been codified. Aqtiva Inc., Green Lightning, Greenpath Industries, HydroPlasma.Tech, Redhill Scientific, US Plasma Engineering, and AJ Plasmatech broaden regional development, although commercial maturity varies materially among them.

Asia Pacific

Asia Pacific is the fastest-growing region at a 36.7% CAGR and will expand from USD 3.22 million in 2025 to USD 76.34 million in 2035. China combines a large nitrogen-consumption base with plasma research programs in Jiangsu, Zhejiang, and Guangdong. India links decentralized production with PM-KUSUM solar infrastructure and smallholder distribution through Plasma Waters and Samunnati. ^{[8]Food and Agriculture Organization, Nitrogen fertilizer consumption data. fao.org} Japan's CEA sector supports high-value horticultural deployment, while South Korea and Australia are emerging commercialization markets. PlasmaLeap's 2025 Tasmania commissioning gives Australia a visible entry point.

Middle East & Africa and Latin America

MEA represented 5.0% of 2025 revenue, with UAE vertical farming and Saudi food-security priorities creating CEA-oriented demand. Latin America held 4.9%; Brazil, Mexico, and Argentina offer scale potential, but capital availability and infrastructure slow adoption relative to Europe and North America. Both regions require cost-optimized systems and locally credible agronomic support before large deployments can develop.

Plasma-Activated Water (PAW) for Fertilization Market Share & Competitive Landscape

VitalFluid led the market with 22% share in 2025, followed by Plasma Waters at 14%, Aqtiva Inc. at an estimated 10%, and PAWER Solutions at 6%. These four suppliers held approximately 52% collectively, while more than 50 smaller entities accounted for the balance. VitalFluid differentiates through continuous greenhouse operation, a combined fertilization and plant-health proposition, and access to the Horticoop distribution channel. Its EUR 5 million 2024 seed round supports greenhouse-program expansion. ^{[9]VitalFluid, Commercial greenhouse PAW deployments and seed funding. vitalfluid.com}

Plasma Waters competes through continuous-flow water activation and its India, Chile, and UK activity. Aqtiva Inc. focuses on APPJ and microbubble systems for North American CEA and organic farms, although its commercial revenue remains estimated while the company progresses through demonstrations. PAWER Solutions targets cost-sensitive open-field and bio-agriculture applications with corona discharge equipment and EU Horizon participation. PlasmaLeap is the highest-capitalized emerging entrant, commissioning its first eNFix unit in Tasmania in 2025 after a USD 30 million Series A.

Major participants also include HydroPlasma.Tech, cNTP AgriTech, Redhill Scientific, Greenpath Industries, Green Lightning, Global Enviro, WIADAP Plasma Tech, US Plasma Engineering, AJ Plasmatech, and Eddaion. Their positions range from commercially deployed fertigation systems to pilot, prototype, and peripheral water-treatment applications. Green Lightning offers a commercially deployed plasma-arc route for on-farm fertilizer generation. Redhill Scientific and Greenpath Industries focus on nitrogen hardware and organic-farming positioning, respectively. cNTP AgriTech, WIADAP Plasma Tech, and US Plasma Engineering remain earlier-stage developers. Global Enviro and Eddaion address agricultural PAW as a secondary application; Eddaion's trace nitrate output places it primarily in sterilization and disinfection rather than fertilization.

N2 Applied is not included in the active competitive landscape following formal insolvency proceedings confirmed on March 26, 2025. Its prior deployments remain relevant as evidence of plasma-treated organic-fertilizer performance and enterprise supply-chain integration, including GEA Group's October 2024 Unilever dairy-farm project. Share is likely to diffuse over the forecast period as emerging suppliers scale and larger agri-input companies evaluate entry. VitalFluid is projected to hold approximately 17% by 2035, while the fragmented remainder will rise to approximately 61%.

Recent Industry Developments

• 2025: PlasmaLeap commissioned its first commercial eNFix plasma-nitrogen unit near Longford, Tasmania, and completed a USD 30 million Series A. The project gives the market a commercial-scale southern-hemisphere reference.

• 2025: Nature Communications published a distributed electric-field plasma nitrogen-fixation study reporting NOx⁻ yields of 9.8 mmol/h and N₂ conversion rates three times higher than many conventional discharge configurations. The result strengthens the efficiency pathway for future reactor designs.